|
[]参考文献[1]CHEN YZ, LIU L, FU XL, et al.Knowledge mapping analysis of the relationship between obesity and cancer[J].Chin J Dis Control Prevent, 2016, 20 (6) :604-608. (in Chinese) 陈燕子, 刘莉, 付晓丽, 等.肥胖与癌症的关系的知识图谱分析[J].中华疾病控制杂志, 2016, 20 (6) :604-608.[2]WONG RJ, CHEUNG R, AHMED A.Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S[J].Hepatology, 2014, 59 (6) :2188.[3]WONG RJ, AGUILAR M, CHEUNG R, et al.Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J].Gastroenterology, 2015, 148 (3) :547.[4]SIEGEL AB, LIM EA, WANG S, et al.Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation[J].Transplantation, 2011, 94 (5) :539.[5]OHKI T, TATEISHI R, SHIINA S, et al.Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH[J].Gut, 2009, 58 (6) :839-844.[6]MOLLER H, MELLEMGAARD A, LINDVIG K, et al.Obesity and cancer risk:a Danish record-linkage study[J].Eur J Cancer, 1994, 30A (3) :344.[7]SAMANIC C, CHOW WH, GRIDLEY G, et al.Relation of body mass index to cancer risk in 362, 552 swedish men[J].Cancer Causes Control, 2006, 17 (7) :901-909.[8]SCHLESINGER S, ALEKSANDROVA K, PISCHON T, et al.Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort[J].Int J Cancer, 2013, 132 (3) :645-657.[9]NAIR S, MASON A, EASON J, et al.Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis[J].Hepatology, 2002, 36 (1) :150-155.
|
|
[10]YI C, WANG X, WANG J, et al.Excess body weight and the risk of primary liver cancer:an updated meta-analysis of prospective studies[J].Eur J Cancer, 2012, 48 (14) :2137.
|
|
[11]RIBATTI D, BELLONI AS, NICO B, et al.Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma[J].Peptides, 2008, 29 (9) :1596-1602.
|
|
[12]DAI K, TIAN DY.Leptin facilitates the proliferation activity of hepatoma cells via regulating cell cycle proteins[J].J Med Postgrad, 2007, 20 (4) :339-342. (in Chinese) 戴锴, 田德英.瘦素通过调控细胞周期蛋白促进人肝癌细胞增殖[J].医学研究生学报, 2007, 20 (4) :339-342.
|
|
[13]YAO M, YAN XD, WANG L, et al.Down-regulating insulinlike growth factor-1 receptor gene transcription on effect of hepatoma growth inhibition[J].Chin J Cancer Prev Treat, 2015, 22 (19) :1528-1533. (in Chinese) 姚敏, 严晓娣, 王理, 等.干扰IGF-1R基因表达对肝癌细胞裸鼠移植瘤生长影响研究[J].中华肿瘤防治杂志, 2015, 22 (19) :1528-1533.
|
|
[14]PARK EJ, LEE JH, YU GY, et al.Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6and TNF expression.[J].Cell, 2010, 140 (2) :197-208.
|
|
[15]ALI KAMKAR MM, AHMAD R, ALSMADI O, et al.Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma:mini-review[J].J Diabetes Metab Disord, 2014, 13:57.
|
|
[16]BARB D, PAZAITOUPANAYIOTOU K, MANTZOROS CS.Adiponectin:a link between obesity and cancer[J].Expert Opinion on Investigational Drugs, 2006, 15 (8) :917-931.
|
|
[17]ZHOU J, LEI W, SHEN L, et al.Expression and significance of leptin and leptin receptor in hepatocellular carcinoma cells[J].Wuhan Univ Med J, 2009, 30 (3) :376-378. (in Chinese) 周晶, 雷伟, 沈磊, 等.瘦素及其受体蛋白在肝癌细胞中的表达及意义[J].武汉大学学报医学版, 2009, 30 (3) :376-378.
|
|
[18]LEROITH D, HELMAN AL.The new kid on the block (ade) of the IGF-1 receptor[J].Cancer Cell, 2004, 5 (3) :201-202.
|
|
[19]YOU M, CONSIDINE RV, LEONE TC, et al.Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice[J].Hepatology, 2005, 42 (3) :568-577.
|
|
[20]SAXENA NK, FU PP, NAGALINGAM A, et al.Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma[J].Gastroenterology, 2010, 139 (5) :1-5.
|
|
[21]DALAMAGA M, DIAKOPOULOS KN, MANTZOROS CS.The role of adiponectin in cancer:a review of current evidence[J].Endocrine Reviews, 2012, 33 (4) :547-594.
|
|
[22]WEBER MM, FOTTNER C, LIU SB, et al.Overexpression of the insulin-like growth factor I receptor in human colon carcinomas[J].Cancer, 2002, 95 (10) :2086-2095.
|
|
[23]KIM SH, REAVEN G.Obesity and insulin resistance:an ongoing saga[J].Diabetes, 2010, 59 (9) :2105-2106.
|
|
[24]BARTH RJ.Insulin resistance, obesity and the metabolic syndrome[J].S D Med, 2011, Spec No:22-27.
|
|
[25]AHMED M.Non-alcoholic fatty liver disease in 2015[J].World J Hepatol, 2015, 7 (11) :1450-1459.
|
|
[26]Group of Fatty Liver and Alcoholic liver Disease, Society of Hepatology, Chinese Medical Association.Guideline for management of non-alcoholic fatty liver diseases[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
|
|
[27]LI LP.Nonalcoholic fatty liver disease and hepatocellular carcinoma[J].J Clin Hepatol, 2016, 32 (3) :432-436. (in Chinese) 李良平.非酒精性脂肪性肝病与肝细胞癌[J].临床肝胆病杂志, 2016, 32 (3) :432-436.
|
|
[28]WENSHENG L, BAKER SS, BAKER RD, et al.Antioxidant mechanisms in nonalcoholic fatty liver disease[J].Current Drug Targets, 2015, 16 (12) :1301-1314.
|
|
[29]XIAO L, YANG L.Gut microbiota and nonalcoholic fatty liver disease[J].J Clin Hepatol, 2017, 33 (4) :774-779. (in Chinese) 肖丽, 杨玲.肠道菌群与非酒精性脂肪性肝病的关系[J].临床肝胆病杂志, 2017, 33 (4) :774-779.
|
|
[30]WANG XY, LI YL.Progress in understanding association of PNPLA3 I148M (rs738409) single nucleotide polymorphism with hepatocellular carcinoma and hepatic cirrhosis[J].World Chin JDig, 2014, 22 (29) :4430-4436. (in Chinese) 王心怡, 李异玲.PNPLA3 I148M (rs738409) SNP与肝硬化及肝细胞癌关系的研究进展[J].世界华人消化杂志, 2014, 22 (29) :4430-4436.
|
|
[31]XU JING, XIN YN, XUAN SY.Polymorphisms in PNPLA3 gene is associated with non-alcoholic fatty liver disease[J].J Clin Hepatol, 2012, 28 (4) :316-320. (in Chinese) 徐静, 辛永宁, 宣世英.PNPLA3基因多态性与非酒精性脂肪性肝病关系的研究进展[J].临床肝胆病杂志, 2012, 28 (4) :316-320.
|
|
[32] XU J, XIN YN, LYU WH, et al.Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease[J].Chin J Hepatol, 2013, 21 (8) :619-623. (in Chinese) 徐静, 辛永宁, 吕维红, 等.PNPLA3 rs738409基因多态性与非酒精性脂肪性肝病遗传易感性的关系[J].中华肝脏病杂志, 2013, 21 (8) :619-623.
|
|
[33]GENG N, JIANG M, ZHANG DD, et al.I148M polymorphism of PNPLA3 gene affects cell cycle of hepatoma carcinoma cell Huh-7[J].Chin J Hepatol, 2015, 23 (5) :328-332. (in Chinese) 耿宁, 姜曼, 张丁丁, 等.PNPLA3基因I148M多态性对肝癌细胞株Huh-7细胞周期的影响[J].中华肝脏病杂志, 2015, 23 (5) :328-332.
|
|
[34]WANG Y, SHEN WX, LU SF, et al.Roles of microRNAs in obesity regulation[J].Chin J Diabetes, 2014, 22 (1) :89-92. (in Chinese) 王杨, 沈卫星, 卢圣锋, 等.微小RNA在肥胖中的研究进展[J].中国糖尿病杂志, 2014, 22 (1) :89-92.
|
|
[35]LIN Q, GAO Z, ALARCON RM, et al.A role of miR-27 in the regulation of adipogenesis[J].Febs Journal, 2009, 276 (8) :2348.
|
|
[36]ZHANG XJ.Development of microRNA-143 in obesity and insulin resistance[J].J Med Postgrad, 2013, 26 (6) :666-668. (in Chinese) 张向君.MicroRNA-143在肥胖及胰岛素抵抗中的研究进展[J].医学研究生学报, 2013, 26 (6) :666-668.
|
|
[37]WANG Y, LU ZT, LI YQ, et al.miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression[J].Chin J cell molecular immunol, 2014, 30 (10) :1076-1079. (in Chinese) 王塬, 逯忠堂, 李尧清, 等.miR-143下调肝癌细胞TLR2的表达并抑制肝癌细胞增殖和侵袭[J].细胞与分子免疫学杂志, 2014, 30 (10) :1076-1079.
|
|
[38]FU DQ, XU TW, WU WY, et al.Expression and function of microRNA-27a in hepatocellular carcinoma[J].Chin J Exp Surg, 2016, 33 (4) :1091-1093. (in Chinese) 傅德强, 许天文, 吴文艺, 等.微小RNA-27a在肝癌组织的表达及其机制[J].中华实验外科杂志, 2016, 33 (4) :1091-1093.
|
|
[39]LI ZW, WU T, FU YX, et al.Expression and roles of MicroRNA-31 in HCC[J].Chin J Clin Pharmacol Ther, 2015, 20 (10) :1098-1101. (in Chinese) 李中文, 吴涛, 付应霄, 等.MicroRNA-31在肝癌中的表达和作用[J].中学临床药理学与治疗学, 2015, 20 (10) :1098-1101.
|
|
[40]MAHDESSIAN H, TAXIARCHIS A, POPOV S, et al.TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content[J].Proc Natl Acad Sci U S A, 2014, 111 (24) :8913-8918.
|
|
[41]JANG WY, BAE KB, KIM SH, et al.Overexpression of Jazf1 reduces body weight gain and regulates lipid metabolism in high fat diet[J].Biochem Biophys Res Commun, 2013, 444 (3) :296-301.
|
|
[42]ZHAO HJ.Progress in the study of leptin and insulin resistance[J].Med Recapitulate, 2010, 16 (11) :1684-1687. (in Chinese) 赵荷珺.瘦素与胰岛素抵抗的研究进展[J].医学综述, 2010, 16 (11) :1684-1687.
|
DownLoad: